Table 2. Clinical manifestations (n = 1,251^a) and hospitalization of adverse effects following immunization, number of doses per event, and rate per 10,000 doses, in children up to 24 months of age. Araraquara, state of São Paulo, Brazil, 2000 to 2013.

Clinical manifestations/Hospitalization		Number of events	Number of doses per event	Rate per 10,000 doses^b
Local
	Pain	189	4,040	2.5
	Nodule	163	4,684	2.1
	Abscess	33	23,138	0.4
	Lymphadenitis	33	23,138	0.4
	Ulcer	1	763,548	0.1
Systemic
	Headache	1	763,548	0.1
	Nausea	10	76,355	0.1
	Diarrhea	23	33,198	0.3
	Vomiting	54	14,140	0.7
	Cyanosis	27	28,280	0.4
	Malaise	23	33,198	0.3
	Irritability	102	7,486	1.3
	Sleepiness	44	17,353	0.6
	Myalgia	7	109,078	0.1
	Exanthema	46	16,599	0.6
	Jaundice	1	763,548	0.1
	Parotitis	20	38,177	0.3
	Fever	344	2,220	4.5
	< 38°C	51	14,971	0.7
	38\|-\|39,4°C	196	3,896	2,6
	≥ 39.5°C	68	11,229	0.9
	Hypotonic-hyporesponsive episode	67	11,396	0.9
	Adenoiditis	18	42,419	0.2
	Arthralgia	1	763,548	0.1
	Hypersensitivity	11	69,413	0.1
	Seizure	25	30,542	0.3
	Loss of consciousness	6	127,258	0.1
	Myelitis	1	763,548	0.1
	Paresis	1	763,548	0.1
Hospitalization		16	47,722	0.2

The 565 cases for which we had information presented 1,251 types of clinical manifestation.

Rate of AEFI for dose of any vaccine.

Table 2. Clinical manifestations (n = 1,251a) and hospitalization of adverse effects following immunization, number of doses per event, and rate per 10,000 doses, in children up to 24 months of age. Araraquara, state of São Paulo, Brazil, 2000 to 2013.